Nuveen Asset Management, LLC - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 48 filers reported holding TALIS BIOMEDICAL CORP in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q1 2022$82,000
-55.9%
53,809
+7.0%
0.00%
Q4 2021$186,000
-52.6%
50,287
-7.7%
0.00%
Q3 2021$392,000
-11.3%
54,484
+36.0%
0.00%
Q2 2021$442,000
+60.7%
40,060
+87.1%
0.00%
Q1 2021$275,00021,4150.00%
Other shareholders

There were no reported owners of TALIS BIOMEDICAL CORP in Q4 2021.

NameSharesValueWeighting ↓
View complete list of TALIS BIOMEDICAL CORP shareholders